SBK Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-8
Closed -$2.65K – 217
2026
Q1
$2.65K Buy
+8
New +$2.72K ﹤0.01% 293

Other funds holding ALNY

SBK Financial's ALNY Position: Q2 2026 in Review

SBK Financial sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 8 shares — an estimated $2.65K sold.

SBK Financial first reported a position in ALNY in Q1 2026 and held it in 1 quarter. The position peaked at $2.65K in Q1 2026. 797 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • SBK Financial reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SBK Financial sold 8 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.65K.
  • SBK Financial first reported a position in Alnylam Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • SBK Financial's Alnylam Pharmaceuticals position peaked at $2.65K in Q1 2026.
  • 797 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.